ID

39287

Description

Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine; ODM derived from: https://clinicaltrials.gov/show/NCT01951677

Lien

https://clinicaltrials.gov/show/NCT01951677

Mots-clés

Versions (1)
  1. 16/12/2019 16/12/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 décembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Exposure to Hepatitis B Virus NCT01951677

Anglais

Eligibility Exposure to Hepatitis B Virus NCT01951677

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 years and above
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
male or female
Description

Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
able to provide written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
willing and able to comply with the protocol for the duration of the study.
Description

Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C0525058
has one or more of
Description

Criteria Quantity Fulfill

Type de données

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1550543
age 40 years or above
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
impaired renal function (creatinine >120 mmol/l or calculated glomerular filtration rate <60mls/min)
Description

Renal Insufficiency | Creatinine measurement, serum | Glomerular Filtration Rate Calculated

Type de données

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
UMLS CUI [3,1]
C0017654
UMLS CUI [3,2]
C0444686
diagnosis of diabetes mellitus (any type)
Description

Diabetes Mellitus Type Any

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0332307
UMLS CUI [1,3]
C1552551
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of prior hepatitis b vaccination
Description

Hepatitis B vaccination

Type de données

boolean

Alias
UMLS CUI [1]
C0474232
history of serious vaccine allergy if in the opinion of the investigator this represents a contraindication to hepatitis b vaccination
Description

Vaccines allergy Serious | Medical contraindication Hepatitis B vaccination

Type de données

boolean

Alias
UMLS CUI [1,1]
C0571550
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0474232
women of childbearing potential unless using a reliable and appropriate contraceptive method, specifically oral contraceptive pill, intrauterine device or mechanical barrier device.
Description

Childbearing Potential | Exception Use of Contraceptive methods | Contraceptives, Oral | Intrauterine Devices | Contraception, Barrier

Type de données

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1524063
UMLS CUI [2,3]
C0700589
UMLS CUI [3]
C0009905
UMLS CUI [4]
C0021900
UMLS CUI [5]
C0004764
pregnant or lactating women.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of systemic autoimmune disease including wegener's granulomatosis, systemic lupus erythematosus, guillain-barre, scleroderma or multiple sclerosis.
Description

Systemic autoimmune disease | Wegener's Granulomatosis | Lupus Erythematosus, Systemic | Guillain-Barre Syndrome | Scleroderma | Multiple Sclerosis

Type de données

boolean

Alias
UMLS CUI [1]
C2895206
UMLS CUI [2]
C3495801
UMLS CUI [3]
C0024141
UMLS CUI [4]
C0018378
UMLS CUI [5]
C0011644
UMLS CUI [6]
C0026769
participation in another clinical trial with an investigational agent within 28 days of the scheduled date of first immunization.
Description

Study Subject Participation Status | Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
any other serious medical, social or mental condition that, in the opinion of the investigator, would be detrimental to the subjects or the study.
Description

Medical condition Serious Impairing Study Subject | Medical condition Serious Impairing Clinical Trial | Social Condition Impairing Study Subject | Social Condition Impairing Clinical Trial | Mental condition Impairing Study Subject | Mental condition Impairing Clinical Trial

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0221099
UMLS CUI [1,4]
C0681850
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0221099
UMLS CUI [2,4]
C0008976
UMLS CUI [3,1]
C0037403
UMLS CUI [3,2]
C0221099
UMLS CUI [3,3]
C0681850
UMLS CUI [4,1]
C0037403
UMLS CUI [4,2]
C0221099
UMLS CUI [4,3]
C0008976
UMLS CUI [5,1]
C3840291
UMLS CUI [5,2]
C0221099
UMLS CUI [5,3]
C0681850
UMLS CUI [6,1]
C3840291
UMLS CUI [6,2]
C0221099
UMLS CUI [6,3]
C0008976
Retour au début de la page

Similar models

Eligibility Exposure to Hepatitis B Virus NCT01951677

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18 years and above
boolean
C0001779 (UMLS CUI [1])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Informed Consent
Item
able to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Protocol Compliance
Item
willing and able to comply with the protocol for the duration of the study.
boolean
C0525058 (UMLS CUI [1])
Criteria Quantity Fulfill
Item
has one or more of
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Age
Item
age 40 years or above
boolean
C0001779 (UMLS CUI [1])
Renal Insufficiency | Creatinine measurement, serum | Glomerular Filtration Rate Calculated
Item
impaired renal function (creatinine >120 mmol/l or calculated glomerular filtration rate <60mls/min)
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0017654 (UMLS CUI [3,1])
C0444686 (UMLS CUI [3,2])
Diabetes Mellitus Type Any
Item
diagnosis of diabetes mellitus (any type)
boolean
C0011849 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Hepatitis B vaccination
Item
history of prior hepatitis b vaccination
boolean
C0474232 (UMLS CUI [1])
Vaccines allergy Serious | Medical contraindication Hepatitis B vaccination
Item
history of serious vaccine allergy if in the opinion of the investigator this represents a contraindication to hepatitis b vaccination
boolean
C0571550 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0474232 (UMLS CUI [2,2])
Childbearing Potential | Exception Use of Contraceptive methods | Contraceptives, Oral | Intrauterine Devices | Contraception, Barrier
Item
women of childbearing potential unless using a reliable and appropriate contraceptive method, specifically oral contraceptive pill, intrauterine device or mechanical barrier device.
boolean
C3831118 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
C0009905 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0004764 (UMLS CUI [5])
Pregnancy | Breast Feeding
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic autoimmune disease | Wegener's Granulomatosis | Lupus Erythematosus, Systemic | Guillain-Barre Syndrome | Scleroderma | Multiple Sclerosis
Item
history of systemic autoimmune disease including wegener's granulomatosis, systemic lupus erythematosus, guillain-barre, scleroderma or multiple sclerosis.
boolean
C2895206 (UMLS CUI [1])
C3495801 (UMLS CUI [2])
C0024141 (UMLS CUI [3])
C0018378 (UMLS CUI [4])
C0011644 (UMLS CUI [5])
C0026769 (UMLS CUI [6])
Study Subject Participation Status | Investigational New Drugs
Item
participation in another clinical trial with an investigational agent within 28 days of the scheduled date of first immunization.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Medical condition Serious Impairing Study Subject | Medical condition Serious Impairing Clinical Trial | Social Condition Impairing Study Subject | Social Condition Impairing Clinical Trial | Mental condition Impairing Study Subject | Mental condition Impairing Clinical Trial
Item
any other serious medical, social or mental condition that, in the opinion of the investigator, would be detrimental to the subjects or the study.
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0221099 (UMLS CUI [1,3])
C0681850 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0221099 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0037403 (UMLS CUI [3,1])
C0221099 (UMLS CUI [3,2])
C0681850 (UMLS CUI [3,3])
C0037403 (UMLS CUI [4,1])
C0221099 (UMLS CUI [4,2])
C0008976 (UMLS CUI [4,3])
C3840291 (UMLS CUI [5,1])
C0221099 (UMLS CUI [5,2])
C0681850 (UMLS CUI [5,3])
C3840291 (UMLS CUI [6,1])
C0221099 (UMLS CUI [6,2])
C0008976 (UMLS CUI [6,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial